A4.6 Nicotinic acetylcholine receptor ligands inhibit osteoclastogenesis by blocking RANKL-induced calcium-oscillation and induction of NFATC1 and CFOS

P Mandl; D Győri; T Karonitsch; S Blüml; S Hayer; A Mócsai; JS Smolen; K Redlich

doi:10.1136/annrheumdis-2013-205124.133

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

Podcasts
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

4. Bone diseases

A4.6 Nicotinic acetylcholine receptor ligands inhibit osteoclastogenesis by blocking RANKL-induced calcium-oscillation and induction of NFATC1 and CFOS

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Mandl P, Győri D, Karonitsch T, et al

A4.6 Nicotinic acetylcholine receptor ligands inhibit osteoclastogenesis by blocking RANKL-induced calcium-oscillation and induction of NFATC1 and CFOS

Annals of the Rheumatic Diseases 2014;73:A58-A59.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password